BeStock  

Teva Pharmaceutical Industries TEVA

$39.23 −$0.38 (-0.95%)
Market open · Oct 1, 11:50 am ET · After hours $39.60 0.00%
Open$39.48
Prev close$39.60
Day range$38.53 – $39.54
Volume1.46M
Market cap$45.75B
P/E (TTM)65.4
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$4.14B-0.8% YoY
Operating profit$149.00M-83.4% YoY
Net profit-$575.00M-303.2% YoY
Diluted EPS-$0.49-304.2% YoY
Free cash flow$307.00M+134.4% YoY
Operating cash flow$411.00M

Revenue, last 8 quarters

$4.3BSep '24$4.2BDec '24$3.9BMar '25$4.2BJun '25$4.5BSep '25$4.7BDec '25$4.0BMar '26$4.1BJun '26

Net profit, last 8 quarters

$-390.0MSep '24$-275.0MDec '24$220.0MMar '25$283.0MJun '25$434.0MSep '25$481.0MDec '25$369.0MMar '26$-575.0MJun '26

Diluted EPS by quarter

-0.39Sep '24-0.19Dec '240.18Mar '250.24Jun '250.37Sep '250.41Dec '250.31Mar '26-0.49Jun '26

Free cash flow by quarter

$545.0MSep '24$446.0MDec '24$-232.0MMar '25$131.0MJun '25$233.0MSep '25$1.0BDec '25$-208.0MMar '26$307.0MJun '26

Annual revenue

$16.7BFY20$15.9BFY21$14.9BFY22$15.8BFY23$16.5BFY24$17.3BFY25

Profitability & balance sheet

Gross margin52.5%
Operating margin18.7%
Net margin4.1%
Return on equity9.7%
Return on assets1.8%
Return on invested capital6.5%
Current ratio0.88
Liabilities / assets80.5%
Cash & investments$3.66B
Total debt$16.87B
Net cash (debt)-$13.22B
Free cash flow / sales7.8%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $4.14B $3.98B $17.26B $4.71B $4.48B
Total Operating Revenue $4.14B $3.98B $17.26B $4.71B $4.48B
Cost of Revenue $1.99B $2.01B $8.32B $2.06B $2.18B
Gross Profit $2.15B $1.97B $8.94B $2.66B $2.30B
Operating Expense $2.00B $1.21B $4.99B $1.39B $1.23B
Selling and Admin Expenses $1.03B $1.00B $3.97B $1.12B $973.00M
-Selling & Marketing Expense $717.00M $696.00M $2.69B $753.00M $656.00M
-General & Admin Expense $317.00M $304.00M $1.29B $367.00M $317.00M
Research & Development $970.00M $222.00M $1.01B $267.00M $256.00M
Operating Profit $149.00M $759.00M $3.95B $1.27B $1.08B
Net Non-Operating Interest Income (Expense) -$224.00M -$216.00M -$985.00M -$271.00M -$237.00M
Non-Operating Interest Expense $195.00M $201.00M $916.00M $292.00M $209.00M
Total Other Finance Costs $29.00M $15.00M $69.00M -$21.00M $28.00M
Other Income (Expense) -$379.00M -$107.00M -$1.74B -$916.00M -$194.00M
Special Income (Charges) -$398.00M -$111.00M -$1.79B -$985.00M -$184.00M
-Less:Restructuring and Mergern & Acquisition $55.00M $30.00M $279.00M $37.00M $45.00M
-Less:Impairment of Capital Assets $113.00M $9.00M $1.03B $773.00M $79.00M
-Less:Other Special Charges $230.00M $72.00M $467.00M $155.00M $60.00M
Other Non-Operating Income (Expenses) $19.00M $4.00M $1.00M $18.00M -$10.00M
Pretax Profit -$455.00M $437.00M $1.22B $80.00M $646.00M
Tax $121.00M $67.00M -$180.00M -$390.00M $214.00M
Net Profit -$575.00M $369.00M $1.42B $481.00M $434.00M
Profit from Continuing Operations -$576.00M $369.00M $1.42B $481.00M $434.00M
Net Income to Parent Company -$576.00M $369.00M $1.41B $480.00M $433.00M
Net Income to Common Stockholders -$576.00M $369.00M $1.41B $480.00M $433.00M
Basic EPS -$0.49 $0.32 $1.23 $0.42 $0.38
Diluted EPS -$0.49 $0.31 $1.21 $0.41 $0.37
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
Other Operating Expenses – -$9.00M – – –
Earnings from Equity Interest Net of Tax – -$1.00M $15.00M $11.00M $2.00M
Gain on Sale of Security – – $51.00M – –
-Gain on Sale Of Business – – -$22.00M – –
-Gain on Sale of Property/Plant/Equipment – – $2.00M – –
Minority Interests – – $7.00M $0.00 $1.00M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $39.86B $40.04B $40.75B $40.75B $39.86B
Total Current Assets $13.76B $13.71B $13.95B $13.95B $12.74B
Cash and Cash Equivalents & Short-Term Investments $3.66B $3.74B $3.56B $3.56B $2.20B
-Cash and Cash Equivalents $3.66B $3.74B $3.56B $3.56B $2.20B
Receivables $3.49B $3.39B $3.71B $3.71B $3.81B
-Accounts Receivable $3.49B $3.39B $3.71B $3.71B $3.81B
Prepaid Assets $1.03B $1.07B $1.12B $1.12B $1.12B
Inventory $3.22B $3.18B $3.18B $3.18B $3.32B
Other Current Assets $563.00M $536.00M $538.00M $538.00M $476.00M
Total Non-Current Assets $26.10B $26.33B $26.80B $26.80B $27.12B
Net PPE $4.26B $4.33B $4.43B $4.43B $5.16B
-Gross PPE $4.26B $4.33B $9.15B $9.15B $5.16B
Goodwill and Other Intangible Assets $19.29B $19.43B $19.78B $19.78B $19.88B
-Goodwill $15.84B $15.82B $16.00B $16.00B $15.95B
-Other Intangible Assets $3.45B $3.61B $3.78B $3.78B $3.94B
Non-Current Deferred Assets $2.16B $2.19B $2.19B $2.19B $1.63B
Other Non-Current Assets $387.00M $377.00M $405.00M $405.00M $444.00M
Total Liabilities $32.10B $31.81B $32.83B $32.83B $32.60B
Total Current Liabilities $15.65B $13.53B $13.46B $13.46B $11.49B
Payables $2.72B $2.60B $2.53B $2.53B $2.36B
-Accounts Payable $2.72B $2.60B $2.53B $2.53B $2.36B
Current Accrued Expenses $2.74B $2.62B $2.69B $2.69B $2.99B
Short-Term Debt and Capital Lease Obligation $4.50B $2.61B $1.82B $1.82B $24.00M
-Current Debt $4.50B $2.61B $1.82B $1.82B $24.00M
Current Provisions $3.90B $3.71B $4.14B $4.14B $4.13B
Other Current Liabilities $1.30B $1.45B $1.54B $1.54B $1.43B
Total Non-Current Liabilities $16.45B $18.28B $19.38B $19.38B $21.11B
Long Term Debt and Capital Lease Obligation $12.37B $14.30B $15.27B $15.27B $17.05B
-Long Term Debt $12.09B $14.02B $14.99B $14.99B $16.77B
-Long Term Capital Lease Obligation $282.00M $280.00M $288.00M $288.00M $283.00M
Non-Current Deferred Liabilities $289.00M $273.00M $296.00M $296.00M $399.00M
Other Non-Current Liabilities $3.79B $3.71B $3.81B $3.81B $3.66B
Total Equity $7.76B $8.23B $7.91B $7.91B $7.25B
Stockholders' Equity $7.75B $8.23B $7.91B $7.91B $7.25B
Capital Stock $59.00M $59.00M $58.00M $58.00M $58.00M
-Common Stock $59.00M $59.00M $58.00M $58.00M $58.00M
Additional Paid-In Capital $28.26B $28.20B $28.13B $28.13B $28.04B
Retained Earnings -$13.97B -$13.39B -$13.76B -$13.76B -$14.24B
Less: Treasury Stock $4.13B $4.13B $4.13B $4.13B $4.13B
Gains/Losses Not Affecting Retained Earnings -$2.47B -$2.51B -$2.39B -$2.39B -$2.48B
Minority Interests $4.00M $4.00M $4.00M $4.00M $4.00M
-Accumulated Depreciation – – -$4.73B -$4.73B –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $411.00M -$40.00M $1.65B $1.16B $369.00M
Net cash flow from continuing operations $411.00M -$40.00M $1.65B $1.16B $369.00M
Net Income from Continuing Operations -$575.00M $369.00M $1.42B $481.00M $434.00M
Gain/Loss from Continuing Operations -$12.00M -$8.00M – – –
Depreciation & Depletion & Amortization $241.00M $239.00M $1.00B $260.00M $249.00M
Deferred Tax $25.00M -$22.00M -$671.00M -$595.00M $107.00M
Other Non-Cash Items $743.00M -$54.00M $81.00M -$41.00M $27.00M
Change in Working Capital -$164.00M -$617.00M -$1.37B $229.00M -$561.00M
Net cash flow from investing -$491.00M $229.00M $737.00M $165.00M $135.00M
Net Cash Flow from Continuing Investing Activities -$490.00M $229.00M $737.00M $165.00M $135.00M
Net PPE Purchase and Sale -$104.00M -$168.00M -$501.00M -$142.00M -$136.00M
Net Business Purchase and Sale -$692.00M $42.00M $34.00M $0.00 $8.00M
Net Investment Purchase and Sale -$1.00M $0.00 -$15.00M $25.00M -$13.00M
Net Other Investing Changes -$5.00M $1.00M $5.00M $0.00 $2.00M
Financing Cash Flow -$1.00M $13.00M -$2.15B $40.00M -$453.00M
Net Cash Flow from Continuing Financing Activities -$1.00M $13.00M -$2.15B $40.00M -$453.00M
Net Issuance Payments Of Debt $0.00 -$23.00M -$1.81B $0.00 -$451.00M
Net Other Financing Charges -$1.00M $36.00M -$337.00M $40.00M -$2.00M
Ending Cash Balance $3.66B $3.74B $3.56B $3.56B $2.20B
Net Change in Cash -$81.00M $202.00M $235.00M $1.36B $51.00M
Beginning Cash Balance $3.74B $3.56B $3.30B $2.20B $2.16B
Effect of Exchange Rate Changes -$5.00M -$17.00M $21.00M -$10.00M -$9.00M
Free Cash Flow $307.00M -$208.00M $1.15B $1.02B $233.00M
-Change in Receivables – – -$173.00M – –
-Change in Inventory – – $152.00M – –
-Change in Payables and Accrued Expense – – -$15.00M – –
-Change in Other Current Assets – – -$1.33B – –

Discussion

No comments yet — be the first to weigh in on TEVA.

Leave a comment

Scroll to Top